Home › Funds › Parkman Healthcare Partners LLC › LLY

Parkman Healthcare Partners LLC position in LLY

ELI LILLY & CO · Health Care

Parkman Healthcare Partners LLC reported holding 38,119 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$44.1M, representing 3.98% of its reported portfolio and ranking #2 among its reported holdings. Parkman Healthcare Partners LLC has disclosed LLY holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)38.12K sh
Reported value held$44.11M
Portfolio Weight3.98%
First reportedQ1 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's LLY position evolved

Parkman Healthcare Partners LLC first disclosed a stake in LLY in Q1 2024 at 32,117 shares (US$25.0M). The position peaked in Q3 2026 at 38,119 shares, worth US$44.1M. Across 10 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 38,119 shares valued at US$44.1M — an increase of 3,119 shares quarter over quarter.. Notable position changes include a 30% trim in Q4 2024 (shares rose 7% over the following quarter), a 39% increase in Q1 2025 (shares fell 5% over the following quarter), a 70% trim in Q3 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 32.12K $24.99M New
Q2 2024 31.65K $28.66M Reduce
Q3 2024 40.38K $35.78M Add
Q4 2024 28.16K $21.74M Reduce
Q1 2025 39.19K $32.37M Add
Q2 2025 33.30K $25.96M Reduce
Q3 2025 10.00K $7.63M Reduce
Q1 2026 34.62K $31.84M New
Q2 2026 35.00K $41.98M Add
Q3 2026 38.12K $44.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 34 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), VANGUARD CAPITAL MANAGEMENT LLC (US$62.39B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held LLY?

Parkman Healthcare Partners LLC has disclosed LLY holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is Parkman Healthcare Partners LLC's current position in LLY?

As of Q3 2026, Parkman Healthcare Partners LLC holds 38.12K shares of LLY (ELI LILLY & CO), valued at $44.11M, representing 3.98% of its reported portfolio and ranking #2.

Has Parkman Healthcare Partners LLC been buying or selling LLY?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in LLY. The position peaked in Q3 2026 at 38.12K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.